This quarter's round-up of cutting-edge cancer research includes a way to fight chemo brain, controlling cancer cell death, and...
T-DM1, a HER2-targeted antibody-drug conjugate, improved outcomes for patients with HER2-positive, metastatic breast cancer that had progressed despite prior...
Breast-conserving surgery may be a better option than mastectomy for patients with early-stage breast cancer.
Guest Post by Kent Osborne, MD Director of the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine;...
Eddy Shih-Hsin Yang, MD, PhD, associate professor and Regional Oncology Active Research (ROAR) Southeast Cancer Foundation Endowed Chair at...
Guest Post by Graham A. Colditz, MD, DrPH Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School...
The rapid fire of U.S. Food and Drug Administration (FDA) approvals of new treatments for cancer continued last week...
Guest Post by Anees B. Chagpar, MD, MPH, MBA Yale Cancer Center
After making great strides for some patients with melanoma and lung cancer, immunotherapy drugs are starting to offer hope...
SABCS co-chair and AACR President Carlos L. Arteaga, MD, shares his views on this year's symposium and what the...
Research has fueled significant progress against breast cancer—the overall five-year survival rate for female breast cancer patients in the...